Table 4.
Reason for enquiries reported in studies examining patient medicines helpline services
| Enquiry category | Numbers and percentages of studies reporting the specified category as the primary reason for enquiries | ||
| Total (n=15) | Range of reported percentages of enquiries (mean; WM) | Sample size range (total N) | |
| Adverse effects | 69 24 25 45 52 53 | 21%–46% (33%; 37%) | 56–209 (at least 525*) |
| Administration or dosage | 521 28 46 49 50 | 21%–52% (37%; 34%) | 49–538 (1058) |
| Interactions | 123 | 22% | 500 |
| Appropriateness or safety of medicines | 113 | 50% | 637 |
| Indications, efficacy or mechanisms of action | 151 | 34% | At least 1000† |
| Insufficient information on hospital discharge letter | 112 | 24% | 413 |
Enquiry categories are listed according to the number of studies within each category. There may be overlap between some enquiry categories, since study authors did not use exactly the same categories.
*Two of the six studies did not report their sample size.
†This study reported their sample size as 'over 1000'.
WM, weighted mean (weighted by sample size).